Figure 4.
The effect of expression of dominant-negative RhoA on proliferation and cell-cycle progression. (A) [3H] Thymidine uptake of ckit+ cells expressing dominant-negative RhoA; control (▪), RhoAN19 (□). Data represent the mean ± SEM of 3 independent experiments, *P < .01 versus control group. (B-E) Flow cytometric analysis of cell-cycle status of transduced ckit+ cells. (B-C) Cells expressing the control virus. (D-E) Cells expressing RhoAN19. (C,E) Cells stimulated with SCF for 9 hours. The percentage of cells in each phase of cell cycle is shown at upper right. Data are representative of 4 independent experiments. *P < .05 versus control group.

The effect of expression of dominant-negative RhoA on proliferation and cell-cycle progression. (A) [3H] Thymidine uptake of ckit+ cells expressing dominant-negative RhoA; control (▪), RhoAN19 (□). Data represent the mean ± SEM of 3 independent experiments, *P < .01 versus control group. (B-E) Flow cytometric analysis of cell-cycle status of transduced ckit+ cells. (B-C) Cells expressing the control virus. (D-E) Cells expressing RhoAN19. (C,E) Cells stimulated with SCF for 9 hours. The percentage of cells in each phase of cell cycle is shown at upper right. Data are representative of 4 independent experiments. *P < .05 versus control group.

Close Modal

or Create an Account

Close Modal
Close Modal